DISPOSITION OF ACYL GLUCURONIDES & THEIR PROTEIN ADDUCTS
DISPOSITION OF ACYL GLUCURONIDES & THEIR PROTEIN ADDUCTS
批准号:
6018763
负责人:
PHILIP C SMITH
金额:
$20.0万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-04-01 至 2001-06-30
关键词:
acidity /alkalinity acyl group adduct bile binding proteins blood chemistry chemical models chemical synthesis computer simulation covalent bond drug metabolism gel electrophoresis glucuronides glycation glycine hepatotoxin indocyanine green laboratory rabbit laboratory rat liver metabolism mass spectrometry pharmacokinetics protein sequence toxicant interaction urinalysis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Drugs, other xenobiotics and endogenous compounds that contain the
ubiquitous carboxylic acid functional group are often metabolized by
conjugation with glucuronic acid to form acyl (ester linked)
glucuronides. It is now well documented that such metabolites can reach
appreciable concentrations in blood, are labile, undergoing pH-dependent
intramolecular acyl migration to isomeric conjugates of glucuronic acid
or hydrolysis and may react irreversibly with plasma or tissue proteins,
both in vitro and in vivo. Currently scientists are well aware of the
instability of acyl glucuronides, their potential to react covalently
with proteins and their postulated link with toxicity, through either
apparent untoward immunological responses or by modification of critical
proteins. A better understanding of the phenomenon may lead to newly
developed drugs with less adverse reactions. Drugs metabolized to acyl
glucuronides are still being identified to have unacceptable toxicity as
shown by the withdrawal of suprofen in the U.S. in 1988 and that of
ketorolac from German and French market in 1994. The reaction of acyl
glucuronides with proteins appears to be by either of two mechanisms,
nucleophilic displacement and imine formation after acyl migration,
though which is more dominant or toxicologically significant in vivo has
not been resolved. Until recently, there was no cause-effect
relationship established between covalent adducts formed by acyl
glucuronides and toxicity; nor was there an animal model for any adverse
reactions due to acyl glucuronides. However, recently a relationship
between acyl glucuronide formation rates, instability and observed
hepatobiliary toxicity in mice and rats for a sense of phenyl glycines
under development as drugs was reported. This series of phenyl carboxylic
acid offers an opportunity to systematically study potential mechanisms
for acyl glucuronide mediated toxicity.
These considerations indicate that continued research on the disposition
and reactivity of acyl glucuronides is warranted and lead to the
following research questions: 1. Is there a correlation between covalent
binding of acidic compounds to proteins in vivo or in vitro and observed
toxicity for acids metabolized to acyl glucuronides?; and 2. Can the
reactivity of acyl glucuronides be predicted by understanding of the
chemistry of these acidic compounds and the mechanisms involved in their
binding to proteins? These questions will be addressed through a
coordinated series of in vitro experiments and small animal studies using
reactive and stable acyl glucuronides as well as by computational
modeling of the chemical processes involved.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Shared UPLC-MS/MS for Absolute Quantitative Proteomics
-
批准号:7388732
-
项目类别:
-
资助金额:$38.09万
-
财政年份:2008
-
负责人:PHILIP C SMITH
-
依托单位:
BOTANICAL/DRUG INTERACTIONS IN HIV: GLUCURONIDATION
-
批准号:6774764
-
项目类别:
-
资助金额:$18.25万
-
财政年份:2003
-
负责人:PHILIP C SMITH
-
依托单位:
BOTANICAL/DRUG INTERACTIONS IN HIV: GLUCURONIDATION
-
批准号:6694742
-
项目类别:
-
资助金额:$18.25万
-
财政年份:2003
-
负责人:PHILIP C SMITH
-
依托单位:
ROLE OF INTESTINAL UGT IN DRUG DISPOSITION
-
批准号:6434626
-
项目类别:
-
资助金额:$25.68万
-
财政年份:2002
-
负责人:PHILIP C SMITH
-
依托单位:
ROLE OF INTESTINAL UGT IN DRUG DISPOSITION
-
批准号:6876592
-
项目类别:
-
资助金额:$22.01万
-
财政年份:2002
-
负责人:PHILIP C SMITH
-
依托单位:
ROLE OF INTESTINAL UGT IN DRUG DISPOSITION
-
批准号:6621484
-
项目类别:
-
资助金额:$24.44万
-
财政年份:2002
-
负责人:PHILIP C SMITH
-
依托单位:
ROLE OF INTESTINAL UGT IN DRUG DISPOSITION
-
批准号:6729929
-
项目类别:
-
资助金额:$22.09万
-
财政年份:2002
-
负责人:PHILIP C SMITH
-
依托单位:
海外基金